Drug Database
AM

ampicillin (Bactosone Retard / ampicillin, Cpex)

✓ Approved

CPEX Pharmaceuticals, Inc. · 小分子 · 小分子

什么是 ampicillin?

ampicillin 是一种小分子,由CPEX Pharmaceuticals, Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection。

药物档案

商品名Bactosone Retard, ampicillin, Cpex
公司CPEX Pharmaceuticals, Inc.
药物类别小分子
给药途径Injectable (Others), Intramuscular (IM) Injection
状态Approved

治疗适应症

ampicillin 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsSalmonellosis✓ Approved

相关研究文献

PubMedBMC infectious diseases2026-11-16

Neurolisteriosis in adults: a case series highlighting clinical and diagnostic challenges and review of Indian literature.

Vijayakumar Divya D, Unnikrishnan Gopikrishnan G, Udit Saraf S, Sebastian Chinnu Liz CL et al.

Neurolisteriosis due to Listeria monocytogenes is uncommon but associated with high morbidity and mortality. Diagnosis is often delayed due to heterogeneous clinical presentations, overlap with non-infectious neurological conditions and limited sensitivity of early diagnostic tests. We conducted a single centre retrospective chart review at a tertiary care teaching hospital between January 2024 to March 2026. Adult patients (≥ 18 years) with microbiologically confirmed neurolisteriosis cases were included. Clinical, radiological, microbiological, treatment, and outcome data were analysed descriptively. Of the 1633 CSF samples analysed, 110 (6.7%) were positive for bacterial meningitis, of which 3 (2.7%) were due to Listeria monocytogenes. The median age of patient was 57 years (range: 30-69) with female predominance. One patient had SLE on immunosuppressive therapy while other two were immunocompetent. The median symptoms duration prior to admission was 1 day with common presenting symptoms headache, fever and altered sensorium. Imaging demonstrated hyperintense meningeal or parenchymal enhancement. CSF revealed neutrophilic pleocytosis, elevated protein, and low glucose. CSF and blood cultures were positive in all cases. Delayed appropriate therapy led to deterioration, but targeted ampicillin-based treatment resulted in favourable outcomes. Neurolisteriosis remains a significant diagnostic challenge due to its variable clinical presentation; therefore, maintaining a high index of suspicion and ensuring early recognition with prompt initiation of ampicillin-based therapy are essential for improving patient outcomes.

PMID 43035675
阅读全文 →
PubMedInfection and drug resistance2026-11-16

Antimicrobial Resistance Patterns and Independent Predictors of ESBL Production in Community-Onset Urinary Tract Infections.

Usanmaz Mustafa M, Görgün Selim S, Karslıoğlu Meltem M, Sivrikaya Bahar Büşra BB et al.

Antimicrobial resistance among pathogens causing community-onset urinary tract infections (CO-UTIs) increasingly compromises empirical treatment strategies worldwide. This retrospective cohort study evaluated antimicrobial susceptibility patterns and risk factors for resistance among 205 adults with culture-confirmed community-onset urinary tract infections (CO-UTIs), including both community-acquired and healthcare-associated infections. Multivariable logistic regression models included seven prespecified clinical predictors-age, sex, diabetes mellitus, hypertension, chronic kidney disease, hospitalization within the preceding 90 days, and urinary catheterization-to identify independent predictors of ESBL production and ciprofloxacin resistance. The mean age was 70.5 ± 15.1 years, and 55.1% of patients were male. Escherichia coli was the predominant pathogen, accounting for 58.5% of isolates. ESBL production was detected in 29.3% of isolates. Resistance rates were highest for ampicillin (57.1%) and third-generation cephalosporins (36.6%), whereas carbapenem resistance remained below 8%. Fluoroquinolone resistance was observed in 16.6% of isolates. In multivariable analysis, hospitalisation within the preceding 90 days was the only independent predictor of ESBL positivity (odds ratio 5.23, 95% confidence interval 1.60-17.18; p = 0.006), while no statistically significant independent associations with ciprofloxacin resistance were detected. These findings demonstrate a substantial burden of ESBL-producing pathogens among CO-UTIs, and emphasize the importance of recent healthcare exposure in resistance risk stratification. Risk-adapted empirical therapy and continuous local antimicrobial resistance surveillance are therefore essential components of effective antimicrobial stewardship.

PMID 43036563
阅读全文 →
PubMedThe Journal of surgical research2026-11-16

Antimicrobial Management of Surgical Necrotizing Enterocolitis: A Multi-Institutional Analysis.

Campwala Insiyah I, Patwardhan Utsav M UM, Gollin Gerald G, Yanowitz Toby D TD et al.

Evidence-based antimicrobial regimens are lacking for surgical necrotizing enterocolitis. We evaluated the association between antimicrobial practices and outcomes. We conducted a retrospective cohort analysis of infants with surgical necrotizing enterocolitis (2010-2019) at ten children's hospitals. Demographics, antimicrobial choice, and postoperative outcomes were assessed using multivariable regression. Among 306 neonates (median gestational age 26 wk [interquartile range 25-29], birth weight 850 g [680-1100], age at diagnosis 8.5 wk [3-21]), 15 antimicrobials were used in 94 initial regimens. Postoperatively, 15 were administered in 107 regimens. Pre- and postoperative regimens differed in 67%. The most frequently used antibiotics were ampicillin, clindamycin, gentamicin, and vancomycin. Antifungals were often given to those with lower weight at diagnosis. 34% died during the index admission. No initial antimicrobial agent was associated with mortality. Excluding early deaths, patients received a median of 14 d of postoperative antibiotics. The duration of postoperative antibiotics (>7 d versus < 7 d) was not significantly associated with in-hospital mortality (odds ratio 0.86, P = 0.93). Adjusted regression analyses demonstrated no associations between postoperative antimicrobial choice and enteral autonomy, stoma complications, neurodevelopmental impairment, or cholestasis. Antifungal use was associated with higher odds of late mortality (odds ratio 5.22, P = 0.023), likely secondary to underlying illness severity. Antimicrobial management varied widely. No individual antimicrobial agent improved survival; however, binary analysis of antimicrobial exposure limited conclusions. Longer antimicrobial duration was not associated with improved survival. Prospective randomized studies may help define optimal antibiotic management.

PMID 43038844
阅读全文 →
PubMedFolia microbiologica2026-11-16

Bacterial spectrum, age and calendar-quarter distribution, and antimicrobial susceptibility patterns of isolates recovered from respiratory specimens of children hospitalized with community-acquired pneumonia in Chongqing, China: a three-year retrospective study.

Ren Haijun H, Zhang Jing J, Jin Ling L

Community acquired pneumonia (CAP) continues to be an important cause of admission of children in hospitals. This study focused on bacterial isolates from respiratory samples, age distribution and antibiotic resistance patterns of children below seven years admitted with CAP in Chongqing, China from January 2023 to December 2025. Of the 2,988 patients included in the study, 884 (29.59%) were positive for bacterial culture, with 930 isolates. The predominant species were Haemophilus influenzae (43.01%), Moraxella catarrhalis (22.80%), Streptococcus pneumoniae (14.84%), and Staphylococcus aureus (10.32%). The distribution of recovered isolates differed significantly across age groups (P < 0.01). After adjustment for calendar year, overall culture positivity did not differ significantly across quarters (P = 0.085), although a significant quarter-by-year interaction was observed (P = 0.005), indicating that quarterly patterns varied between years. Year-adjusted quarterly associations were also observed for H. influenzae, M. catarrhalis, and S. aureus. Antimicrobial susceptibility testing showed high non-susceptibility to ampicillin (65.25%) and trimethoprim-sulfamethoxazole (62.33%) among H. influenzae isolates, and to erythromycin and clindamycin (99.19% for each) among S. pneumoniae isolates. Oxacillin non-susceptibility was observed in 20.25% of tested S. aureus isolates, while imipenem non-susceptibility was uncommon among tested Escherichia coli and Klebsiella pneumoniae isolates. These findings support continued regional microbiological surveillance and may inform institutional antimicrobial stewardship. Because nasotracheal suction specimens may contain colonizing organisms, culture recovery alone does not establish the bacterial causes of CAP.

PMID 43035568
阅读全文 →
PubMedSwiss medical weekly2026-11-16

Prevalence of antimicrobial resistance in Campylobacter spp. and Salmonella spp. in Switzerland 2007-2022: a retrospective observational study.

Jung Frederik F, Vogt Deborah R DR, Stephan Roger R, Kronenberg Andreas A et al.

In Switzerland, acute infectious diarrhoea is frequently caused by Campylobacter spp. and Salmonella spp. The rise of antimicrobial resistance complicates treatment and underscores requirements for continuous surveillance. We aimed to analyse the development of antimicrobial resistance in Campylobacter spp. and Salmonella spp. isolated from human samples in Switzerland over time. We conducted a retrospective observational analysis using the ANRESIS database, covering the period from January 2007 to December 2022. The study included 47,498 Campylobacter spp. isolates and 5964 Salmonella enterica isolates. Antimicrobial resistance was categorised according to CLSI or EUCAST. Descriptive statistical analyses were performed to explore resistance over time, focusing on pathogens and invasive versus non-invasive isolates. The majority of Campylobacter isolates were Campylobacter jejuni (80.4%) and Campylobacter coli (7%). Resistance to ciprofloxacin in Campylobacter jejuni increased from 38% in 2007 to 81% in 2022. Resistance to doxycycline and tetracycline also rose sharply between 2012 and 2014, reaching approximately 37% by 2022. Resistance to macrolides remained consistently low (<1%) throughout the study period. Campylobacter coli exhibited higher resistance levels compared to Campylobacter jejuni, with notable increases in resistance to ciprofloxacin (73%) and macrolides (approximately 15%) by 2022. Non-typhoidal Salmonella accounted for 95.4% of all Salmonella isolates, with serovars Enteritidis (32%) and Typhimurium (15%) being most prevalent. Resistance to ciprofloxacin/norfloxacin was observed in about 10% of isolates, with an increase noted around 2013-2014. High resistance levels were found for amoxicillin/ampicillin (23%) and gentamicin (70%), while resistance to third- and fourth-generation cephalosporins and carbapenems remained low (<1%). A decline in nitrofurantoin resistance was also observed over time. The increasing prevalence of antimicrobial resistance in Campylobacter spp. and Salmonella spp. in Switzerland emphasises the critical need for ongoing surveillance and judicious antibiotic use.

PMID 43037560
阅读全文 →
PubMedFrontiers in microbiology2026-11-15

Genetic, biochemical, and structural characterization of a novel KLUS subgroup of CTX-M-type extended-spectrum β-lactamases reveals an evolutionarily distinct lineage with unique functional properties.

Huang Zhenzhou Z, Li Jun J, Liu Xiao X, Zeng Lingyi L et al.

Extended-spectrum β-lactamases (ESBLs), particularly the CTX-M family, have progressively undermined the clinical utility of β-lactam antibiotics. Herein, we identified and characterized a novel CTX-M subgroup designated KLUS, and investigated its taxonomic position and functional properties. Phylogenetic analysis combined with genetic distance calculations supported KLUS as a distinct lineage, with inter-subgroup distances significantly exceeding intra-subgroup distances and distinct clustering (bootstrap support >95%), consistent with the previously established family-wide CTX-M classification. Recombinant plasmids harboring each of the four bla KLUS alleles were constructed in E. coli BL21 (DE3), with optimal expression achieved using 1.0 mM IPTG at 30 °C for 5 h. Minimum inhibitory concentration (MIC) determinations revealed that KLUS-1 through KLUS-3 conferred high-level resistance to ampicillin and ceftriaxone, moderate resistance to cefotaxime, and minimal resistance to ceftazidime (MIC < 0.125 μg/mL). KLUS-4 exhibited enhanced ceftazidime resistance (MIC = 8 μg/mL) and a reduced inhibitor response at the phenotypic level (a 16-fold reduction of the cefotaxime MIC with clavulanic acid, in contrast to KLUS-1, where clavulanic acid reduced the MIC to <0.015 μg/mL). β-lactamase inhibitors reduced cefotaxime MICs far exceeding 16-fold in KLUS-1 through KLUS-3, consistent with ESBL phenotypes. Steady-state kinetic analyses demonstrated subtype-dependent catalytic efficiencies that were highest for ampicillin and penicillin G in KLUS-2/3/4 and for ceftriaxone in KLUS-1, broadly consistent with MIC results. The substantially lower catalytic efficiency for ceftazidime may explain its reduced resistance phenotype. Structural modeling revealed that KLUS enzymes comprise 11 α-helices and 5 β-sheets, with a conserved catalytic cavity and SDN loop. Twenty-three unique amino acid substitutions distinguish KLUS from CTX-M-2. V77I (pre-protein positions 106) is located proximal to the Ω-loop region, and any functional contribution of this conservative substitution remains speculative. These findings expand the known diversity of CTX-M β-lactamases; the clinical significance of KLUS requires further investigation in clinical isolates.

PMID 43031947
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多ampicillin